CROlife

CROlife is a private, full-service Contract Research Organization based in Milan, Italy, offering comprehensive clinical development services. The company leverages its strong therapeutic expertise in oncology, infectious diseases, and rare diseases, along with deep regulatory knowledge and a robust network of site collaborations, to deliver efficient and compliant trial management. As a service provider, it is revenue-generating, operating under ISO 9001:2015 certification, and is led by its founders Paolo Cioccetti and Anna Rita Bigioni. Its business model is focused on providing outsourced R&D services to life sciences sponsors, positioning it in the competitive but growing global CRO market.

Integrated clinical trial service platform leveraging regulatory expertise, therapeutic specialization (oncology, infectious disease, rare disease), a strong network of KOLs and clinical sites, ISO 9001:2015-certified Quality Management System, and agile project management methodologies.

Operates in the highly competitive global CRO market, competing against large multinational firms (e.g., IQVIA, ICON) and smaller regional specialists. Differentiates through deep therapeutic expertise in complex diseases, a strong EU/Italian regulatory focus, and a positioned as a high-touch, mid-sized service provider.